| Literature DB >> 33719087 |
M James1, M Philippidou1, M Duncan1, S Goolamali1, T Basu1, S Walsh1.
Abstract
Entities:
Mesh:
Substances:
Year: 2021 PMID: 33719087 PMCID: PMC8251369 DOI: 10.1111/ced.14605
Source DB: PubMed Journal: Clin Exp Dermatol ISSN: 0307-6938 Impact factor: 4.481
Figure 1(a) Widespread erosions and erythema 10 days prior to hospital admission; (b) florid, palpable satellite purpura with pustular‐appearing centres and ongoing vulval erosions, taken on day of admission; (c) improvement in purpuric rash and erosions (biopsy site on right inner thigh), taken after 2 days of intravenous (IV) zinc therapy; (d) closer image of satellite lesions in part (c); (e) dramatic improvement after five doses of IV zinc; (f) postinflammatory dyspigmentation 2 weeks following discharge.
Figure 2(a) This section demonstrates the late stages of the skin manifestations of zinc‐deficiency dermatitis with cytoplasmic vacuolation, focal ulceration and epidermal necrosis; (b) intraepidermal vesicles and subcorneal pustules filled with neutrophils. Haematoxylin and eosin stain, original magnification (a) × 40; (b) × 200. (c) Immunohistochemistry for CD1a showed that the skin sample was negative for Langerhans cells, as can be seen in zinc‐deficiency dermatitis (original magnification × 19).